Genentech, a member of the Roche Group, has more than 40 years of experience in the field of biotechnology. Genentech is researching and developing new treatments for people living with a range of eye diseases that cause significant visual impairment and blindness, including wet age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), geographic atrophy (GA), and other retinal diseases.
Email Address: genentech_ophtha-d@gene.com
Telephone: (877) 436-3683
Address: 1 DNA Way, South San Francisco, CA 94080
This virtual series is provided by iVista Medical Education, Inc. | events@ivistameded.com | www.ivistamedicaleducation.com